## HBAN: Huntington Bancshares Incorpora - XLF: Financial Services

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 5.0% in mid entry zone (3.0-6.0%), top quartile (88th pct) cross-sectional ranking. Short-term MRS_5 (3.8%) confirms momentum alignment. Strong momentum (+4.0% 5-day acceleration). Outperforming sector by 3.2%. Caution: overbought RSI (78).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($17.19)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Huntington Bancshares Inc Participates in 2025 Goldman Sachs Conference**
- Source: TradingView | 20251209T212450 | Somewhat-Bullish | Relevance: 99%
-  Huntington Bancshares Inc. (HBAN) will present at the Goldman Sachs Financial Services Conference on December 10, 2025. CEO Steve Steinour and CFO Zach Wasserman will highlight forward-looking statements, strategic plans, and discuss the merger with Cadence Bank, economic conditions, and regulatory impacts. The presentation slides will be available on Huntington's website.

**2. Huntington National Bank expands presence in South Carolina with new branches**
- Source: Retail Banker International | 20251209T090812 | Bullish | Relevance: 99%
-  Huntington National Bank has opened its first full-service branches in Charleston and Greenville, South Carolina, as part of a strategy to launch approximately 55 new branches across the Carolinas. This expansion builds on earlier openings in South Carolina and North Carolina in May, and the bank also recently agreed to acquire Cadence Bank to further scale operations in the Southern US. These moves aim to position Huntington among the top 10 US banks by size after both acquisitions are complete.

**3. Is Huntington Stock A Buy Now?**
- Source: StocksToTrade | 20251210T212546 | Bullish | Relevance: 99%
-  Huntington Bancshares (HBAN) stock has seen a 3.35% increase due to investor optimism from quarterly earnings. The company is streamlining operations by downsizing Cadence Bank's workforce post-acquisition and has received a $100+ million equity infusion for expansion into aerospace and medical technology. Jefferies raised Huntington's price target to $20, maintaining a "Buy" rating, signaling confidence in its future growth despite ongoing scrutiny of the Cadence merger's shareholder benefits.

**4. Huntington Bancshares Incorporated Decreases Its Prime Rate To 6.75 Percent**
- Source: Barchart.com | 20251210T220815 | Neutral | Relevance: 99%
-  Huntington Bancshares Incorporated announced a decrease in its prime rate from 7.00 percent to 6.75 percent, effective December 11, 2025. This follows a previous rate change on October 30, 2025, where the rate decreased from 7.25 percent to 7.00 percent. Huntington is a $223 billion asset regional bank holding company headquartered in Columbus, Ohio.

**5. Huntington Bank to trim staff in Texas after Cadence acquisition**
- Source: The Columbus Dispatch | 20251209T153214 | Neutral | Relevance: 98%
- Huntington Bancshares plans to cut jobs at Texas-based Cadence Bank following its $7.4 billion acquisition, which aims to expand Huntington's presence in Texas, a key growth market. While some initial layoffs are expected, Huntington intends to eventually create more jobs in Texas and move roles from other regions to capitalize on the state's economic growth. This acquisition is part of a broader strategy for regional lenders to expand and will push Huntington into a more stringent regulatory classification.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Piper Sandler | $16 | $15 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Piper Sandler | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 31 ($0.10M) |
| Sells | 5 ($0.87M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+0.4%)
- Blackrock Inc.: 9.5% (-3.0%)
- State Street Corpora: 5.1% (-0.8%)
- Price (T.Rowe) Assoc: 4.3% (-2.2%)
- Boston Partners: 4.3% (+3.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- M&A activity or partnership announcements may unlock value.
- Momentum building: MRS_10 improving +4.0% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.94 elevated, pricing in significant growth expectations. Forward P/E 11.6x stretched relative to 5% growth. Quality metrics strong (margin 30%). Balance sheet: strong liquidity (63.0x). Revenue growth strong at 36% YoY. Analyst sentiment positive (1 raises, avg +7%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $28.2B |
| Beta | 0.98 |
| 52W Range | $11.92 - $18.03 |
| Short Interest | 6.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.94 |
| Forward P/E | 11.6 |
| Current P/E | 12.2 |
| YoY Growth | 5.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 1.0% to 5.0% (+4.0% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 88th percentile. MRS_5 at 3.8% confirms short-term momentum alignment. Outperforming sector by 3.2pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 78, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 5.02% (CS: 88) | Strong |
| RSI_14 | 77.9 | Overbought |
| MACD Histogram | 0.17 | Bullish |
| vs SMA20 | 1.096x | Above |
| vs SMA50 | 1.115x | Above |
| vs SMA200 | 1.120x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $17.91
- **Stop Loss:** $17.19 (4.0% risk)
- **Target:** $18.99 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1916
- **Position Value:** $34,315.56
- **Portfolio %:** 34.32%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-22 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.38 | $0.41 | +9.1% |
| 2025Q2 | $0.33 | $0.34 | +1.7% |
| 2025Q1 | $0.31 | $0.34 | +8.5% |
| 2024Q4 | $0.31 | $0.34 | +10.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*